Abstract:Objective :To detect serum soluble intercellular adhesion molecule-1 ( sICAM-1) expression level in breast cancer , explore the relationship between serum sICAM- 1 and clinical pathology indexes of breast cancer, and analyze its clinical significance. Methods :61 Patients with breast cancer and 23 patients with benign breast tumour were enrolled. Serum concentration of sICAM-1 was detected by ELISA. Results :①The average concentration of serum sICAM-1 in breast cancer was 1389.46+648.91ng/ml, and that of the benign tumor group was (879.72+378.62 ng/ml), There was significant difference among the two groups(P<0.001), serum SICAM-1 in breast cancer with lymph node metastasis group was significantly higher than breast cancer without lymph node metastasis group, (P< 0.001), serum sICAM-1 in stage Ⅲ-Ⅳ breast carcer patients was significantly higher than stageⅠ-Ⅱ breast cancer patients(P<0.05). ②When serum sICAM-1 was set to 1186.87ng/ml , it had the best cut-off value to distinguish the breast cancer from breast benign tumor; When serum sICAM-1 was set to 1257.38ng/ml , it had the best cut-off value to judge breast cancer metastasis.③There was no significant correlation between serum sICAM-1 and pathology classification, age, tumor size, ER, PR, Ki67 and HER-2 .(P > 0.05). Conclusions :The serum sICAM-1 level can be used as a dynamic observating index of breast cancer. Measurement of sICAM-1 might be of certain clinical values in judging tumor development , metastasis and recurrence.
吴琼, 王堃, 向满林, 易斌. 可溶性细胞间粘附分子-1在乳腺癌患者血清中表达的临床意义[J]. 实用预防医学, 2016, 23(5): 630-633.
WU Qiong, WANG Kun, XIANG Man-lin, YI Bin. Expression of circulating soluble ICAM-1 in breast carcinoma and its clinical significance. , 2016, 23(5): 630-633.
[1] R. Siegel, D.Naishadham, andA. Jemal, “Cancer statistics, 2013,”[J]. CA: Cancer Journal for Clinicians,2013,63(1):11-30. [2] 斯诚. 血清肝细胞生长因子和转化生长因子–β在乳腺癌血清中的表达及临床意义[J].实用预防医学,2014,21(6):747-749. [3] Kaei N,Hisashi N,Yasuko E,et al. Serum levels of soluble intercellular cerrical cancer[J].Gynecologic Encology,1997,65:304. [4] Sheen-Chen SM, Eng HL, Sheen CW, Cheng YF, Chou FF, Chen WJ. Serum levels of circulating intercellular adhesion molecule-1 in patients with breast cancer[J]. Anticancer Res, 1997,17: 2823-6. [5] Byrne GJ, Ghelial A, Iddon J, Blann AD, Venizelos V, Kumar S, Howell A, Bundred NJ. Serum soluble vascular cell adhesion molecule-1: role as a surrogate marker of angiogenesis[J].J Natl Cancer Inst ,2000, 92: 1329-36. [6] 姜波, 吴红, 陈世锋, 等. 可溶性细胞间黏附分子-1 和可溶性选择素E 在自身免疫性风湿病中的表达[J].中华风湿病学杂志,2006, 10(4): 230-232. [7] 周秦, 陈基善, 罗四维,等. CTGF 、PDGF -BB 、sICAM -1 在评价肝纤维化程度中的应用[J].实用预防医学,2010,17(6):1060-1063. [8] Kamezaki S, Kurozawa Y, Iwai N, Hosoda T, Okamoto M, Nose T. Serum levels of soluble ICAM-1 and VCAM-1 predict pre-clinical cancer[J]. Eur J Cancer ,2005, 41: 2355-9. [9] Suarez-Carmona M1,2, Bourcy M1, Lesage J3, ea tl. Soluble factors regulated by epithelial-mesenchymal transition mediate tumour angiogenesis and myeloid cell recruitment [J].J Pathol, 2015 Apr 16. doi:10.1002/path.4546. [Epub ahead of print] [10] Hassan AM1, Alm El-Din MA, Nagy H ,ea tl.Significance of autotaxin activity and overexpression in comparison to soluble intercellular adhesion molecule in thyroid cancer[J]. Int J Biol Markers, 2013,28(1):84-91. [11] Parfiniewicz B1, Pendzich J, Gruchlik A, ea ti.Impact of celecoxib on soluble intercellular adhesion molecule-1 and soluble e-cadherin concentrations in human colon cancer cell line cultures exposed to phytic acid and TNF-alpha[J]. Acta Pol Pharm,2012, 69(6):1283-90. [12] Z Dong, S Fu1, X Xu,ea tl.Leptin-mediated regulation of ICAM-1 is Rho/ROCK dependent and enhances gastric cancer cell migration[J]. British Journal of Cancer,2014,110(7),1801-1810. [13] Lu Yang, Tianyong Fan, Qiang Wei,ea tl.Transient Variations in the Serum Concentrations of Cell Adhesion Molecules Following Retroperitoneal Laparoscopic and Open Radical Nephrectomy for Localized Renal-Cell Carcinoma[J].JOURNAL OF ENDOUROLOGY ,2012,26(10):1323-1328. [14] Anna Thielemann1, Aleksandra Baszczuk1, Zygmunt Kopczyński1,ea tl. The clinical usefulness of assessing the concentration of cell adhesion molecules sVCAM-1 and sICAM-1 in the serum of women with primary breast cancer[J]. contemporary oncology ,2014, 18(4)252-259. [15] D.M. O’Hanlon, H. Fitzsimons, J. Lynch, S. Tormey,ea tl. Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1)in breast carcinoma[J]. European Journal of Cancer, 2002,38:2252-2257. [16] Jukkola A,Bloigu R,Soini Y,et al. CerbB-2 positivity is a factor for poor prognosis in breast cancer patients[J]. European Journal of Cancer,2000,36(14) : 755-761. [17] 左文述.现代乳腺肿瘤学[M].第2版.济南: 山东科学技术出版社,2006 ,319-335.